From: HIV-1 co-receptor usage:influence on mother-to-child transmission and pediatric infection
Gene | Polymorphism | Influence on | Ref. | |
---|---|---|---|---|
 |  | MTCT risk | Disease progression |  |
CCR5 | delta32 | Decreased | Delayed | 53,63 |
CCR5 | 59029A | Augmented | Accelerated | 62 |
CCR2 | 64I | Contradicting results | Delayed | 63-65 |
CX3CR1 | I249 | No effect | Accelerated | 67 |
CD4 | C868T | Augmented, when heterozygously expressed in the children | unknown | 69 |
DC-SIGN | p-336C and p-201A | Augmented, when expressed in the children | unknown | 70 |
DC-SIGN | exon 4 : R198Q, E214D, R221Q, and L242V | Augmented, when expressed in the children | unknown | 70 |
DC-SIGNR | H1 and H3 | Augmented | unknown | 71 |
CCL3 | Copy number variation | Augmented, when present in the children | unknown | 72 |
SDF-1 | 3’UTR 801A | Augmented, when present in the mother | Accelerated | 62, 73-76 |